Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Magnesium Sulfate for Controlled Hypotension in Rhinoplasty
NCT05880693Phase 1Completed
- Start
- Jan 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dexmedetomidine and magnesium sulfate in hypotension. Primary endpoint: Bleeding score at 24 hours. Started Jan 2022; status: completed.
02
Drugs
dexmedetomidinemagnesium sulfate
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT05880693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05880693.